Drugs / CKR-051
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05833906 | Apr 2023 → Jan 2024 | — | CK Regeon Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CKR-051 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05833906 ↗ |
| Route | Other | “After Transdermal Administration” NCT05833906 ↗ |